GENOFOCUS

The current price of 187420 is 4025 KRW — it has decreased by 4.51% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOFOCUS stocks are traded under the ticker 187420.

187420 stock is 5.38% volatile and has beta coefficient of 1.00. Check out the list of the most volatile stocks — is GENOFOCUS there?

Yes, you can track GENOFOCUS financials in yearly and quarterly reports right on TradingView.

187420 stock has risen by 8.20% compared to the previous week, the month change is a 8.94% fall, over the last year GENOFOCUS has showed a 13.25% decrease.

187420 net income for the last quarter is ‪3.07 B‬ KRW, while the quarter before that showed ‪−4.54 B‬ KRW of net income which accounts for 167.57% change. Track more GENOFOCUS financial stats to get the full picture.

No, 187420 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 187420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOFOCUS stock right from TradingView charts — choose your broker and connect to your account.

187420 reached its all-time high on Jul 7, 2015 with the price of 26550 KRW, and its all-time low was 2350 KRW and was reached on Mar 20, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 66.00 employees. See our rating of the largest employees — is GENOFOCUS on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOFOCUS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOFOCUS stock shows the sell signal. See more of GENOFOCUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOFOCUS EBITDA is ‪−4.82 B‬ KRW, and current EBITDA margin is −17.86%. See more stats in GENOFOCUS financial statements.